ATE235485T1 - Cyclische verbindungen zur behandlung von dyslipidämien, atheriosklerose und diabetes, pharmazeutische zusammensetzungen und herstellungsverfahren - Google Patents
Cyclische verbindungen zur behandlung von dyslipidämien, atheriosklerose und diabetes, pharmazeutische zusammensetzungen und herstellungsverfahrenInfo
- Publication number
- ATE235485T1 ATE235485T1 AT99934643T AT99934643T ATE235485T1 AT E235485 T1 ATE235485 T1 AT E235485T1 AT 99934643 T AT99934643 T AT 99934643T AT 99934643 T AT99934643 T AT 99934643T AT E235485 T1 ATE235485 T1 AT E235485T1
- Authority
- AT
- Austria
- Prior art keywords
- dyslipidemia
- diabetes
- treatment
- atheriosclerosis
- pharmaceutical compositions
- Prior art date
Links
- 208000032928 Dyslipidaemia Diseases 0.000 title abstract 2
- 208000017170 Lipid metabolism disease Diseases 0.000 title abstract 2
- 150000001923 cyclic compounds Chemical class 0.000 title abstract 2
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/08—1,3-Dioxanes; Hydrogenated 1,3-dioxanes condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9809164A FR2781222A1 (fr) | 1998-07-17 | 1998-07-17 | Composes cycliques utilisables dans le traitement de dyslipidemies, de l'atherosclerose et du diabete, compositions pharmaceutiques les contenant et procede de preparation |
| PCT/EP1999/004831 WO2000004011A1 (en) | 1998-07-17 | 1999-07-09 | Cyclic compounds useful in the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE235485T1 true ATE235485T1 (de) | 2003-04-15 |
Family
ID=9528730
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99934643T ATE235485T1 (de) | 1998-07-17 | 1999-07-09 | Cyclische verbindungen zur behandlung von dyslipidämien, atheriosklerose und diabetes, pharmazeutische zusammensetzungen und herstellungsverfahren |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6528538B1 (de) |
| EP (1) | EP1098893B1 (de) |
| JP (1) | JP2002520407A (de) |
| KR (1) | KR20010070966A (de) |
| CN (1) | CN1309655A (de) |
| AT (1) | ATE235485T1 (de) |
| AU (1) | AU753287B2 (de) |
| BR (1) | BR9912138A (de) |
| CA (1) | CA2337481A1 (de) |
| DE (1) | DE69906303T2 (de) |
| DK (1) | DK1098893T3 (de) |
| ES (1) | ES2192853T3 (de) |
| FR (1) | FR2781222A1 (de) |
| HK (1) | HK1039615A1 (de) |
| HU (1) | HUP0103411A3 (de) |
| ID (1) | ID27854A (de) |
| NO (1) | NO20010266L (de) |
| PL (1) | PL345397A1 (de) |
| PT (1) | PT1098893E (de) |
| SK (1) | SK482001A3 (de) |
| WO (1) | WO2000004011A1 (de) |
| ZA (1) | ZA200101303B (de) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6982251B2 (en) | 2000-12-20 | 2006-01-03 | Schering Corporation | Substituted 2-azetidinones useful as hypocholesterolemic agents |
| HU230253B1 (hu) | 2001-01-26 | 2015-11-30 | Merck Sharp & Dohme Corp | Peroxiszóma proliferátor-aktivált receptor (PPAR) aktivátor(ok) és szterin-abszorpció inhibitor(ok) kombinációi és alkalmazásuk vaszkuláris indikációk kezelésére |
| DK1355644T3 (da) | 2001-01-26 | 2006-10-23 | Schering Corp | Anvendelse af substituerede azetidinonforbindelser til behandling af sitosterolæmi |
| US7071181B2 (en) | 2001-01-26 | 2006-07-04 | Schering Corporation | Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors |
| TWI311133B (en) | 2001-04-20 | 2009-06-21 | Eisai R&D Man Co Ltd | Carboxylic acid derivativeand the salt thereof |
| US7371777B2 (en) | 2001-08-17 | 2008-05-13 | Eisai Co., Ltd. | Cyclic compound and PPAR agonist |
| JP2005504091A (ja) | 2001-09-21 | 2005-02-10 | シェーリング コーポレイション | ステロール吸収阻害剤としてアゼチジノンを用いる黄色腫の処置 |
| US7056906B2 (en) | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
| US7053080B2 (en) | 2001-09-21 | 2006-05-30 | Schering Corporation | Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors |
| WO2004043457A1 (en) | 2002-11-06 | 2004-05-27 | Schering Corporation | Cholesterol absorptions inhibitors for the treatment of autoimmune disorders |
| JP2006519869A (ja) | 2003-03-07 | 2006-08-31 | シェーリング コーポレイション | 置換アゼチジノン化合物、置換アゼチジノン化合物を調製するためのプロセス、それらの処方物および使用 |
| US7459442B2 (en) | 2003-03-07 | 2008-12-02 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| JP4589919B2 (ja) | 2003-03-07 | 2010-12-01 | シェーリング コーポレイション | 高コレステロール血症の処置のための、置換アゼチジノン化合物、これらの処方物および使用 |
| CA2517571C (en) | 2003-03-07 | 2011-07-05 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| EP1622569B1 (de) | 2003-04-24 | 2015-12-02 | Incyte Corporation | Aza-spiro-alkan-derivate als hemmer von metallproteasen |
| EA200601295A1 (ru) * | 2004-01-09 | 2006-12-29 | Кадила Хелзкэр Лимитед | Производные 1,3-диоксана и их аналоги, применимые для лечения i.a. ожирения и диабета |
| JP2008510696A (ja) * | 2004-08-20 | 2008-04-10 | カディラ ヘルスケア リミティド | 新規抗糖尿病化合物 |
| CN100389112C (zh) * | 2004-12-16 | 2008-05-21 | 中国石油化工股份有限公司 | 一类环状缩醛和缩酮化合物及其应用 |
| JP5009314B2 (ja) * | 2006-02-27 | 2012-08-22 | カディラ・ヘルスケア・リミテッド | １，３−ジオキサンカルボン酸 |
| CA2651598A1 (en) * | 2006-05-18 | 2007-11-29 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
| US7910108B2 (en) * | 2006-06-05 | 2011-03-22 | Incyte Corporation | Sheddase inhibitors combined with CD30-binding immunotherapeutics for the treatment of CD30 positive diseases |
| WO2016056031A1 (en) | 2014-10-08 | 2016-04-14 | Council Of Scientific & Industrial Research | Novel diol compounds synthesis and its use for formal synthesis of (2r, 3 s)-3-hydroxypipecolic acid |
| US9637575B2 (en) * | 2014-12-31 | 2017-05-02 | W. R. Grace & Co. -Conn. | Catalyst system, olefin polymerization catalyst components comprising at least an internal electron donor compound, and methods of making and using the same |
| EP4073021A4 (de) * | 2019-12-13 | 2024-02-28 | Specialty Operations France | Herstellung von benzolderivaten |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4032536A (en) * | 1976-07-22 | 1977-06-28 | Janssen Pharmaceutica N.V. | (1h-benzimidazol-2-yl)carbamates |
| US5179216A (en) * | 1990-08-16 | 1993-01-12 | American Home Products Corporation | N,n', n'-trisubstituted-5-bisaminomethylene-1,3-dioxane-4,6-dione inhibitors of acyl-coa:cholesterol-acyl transferase |
| TW209868B (de) * | 1991-04-04 | 1993-07-21 | Yoshitomi Pharmaceutical | |
| DE19637840A1 (de) * | 1996-09-17 | 1998-03-19 | Henkel Kgaa | Verwendung von geminalen Dialkoxyalkansäureestern zur Herstellung von desodorierenden Körperpflegemitteln |
-
1998
- 1998-07-17 FR FR9809164A patent/FR2781222A1/fr not_active Withdrawn
-
1999
- 1999-07-09 AT AT99934643T patent/ATE235485T1/de not_active IP Right Cessation
- 1999-07-09 KR KR1020017000647A patent/KR20010070966A/ko not_active Withdrawn
- 1999-07-09 PT PT99934643T patent/PT1098893E/pt unknown
- 1999-07-09 JP JP2000560117A patent/JP2002520407A/ja active Pending
- 1999-07-09 SK SK48-2001A patent/SK482001A3/sk unknown
- 1999-07-09 ID IDW20010261A patent/ID27854A/id unknown
- 1999-07-09 HU HU0103411A patent/HUP0103411A3/hu unknown
- 1999-07-09 DK DK99934643T patent/DK1098893T3/da active
- 1999-07-09 EP EP99934643A patent/EP1098893B1/de not_active Expired - Lifetime
- 1999-07-09 WO PCT/EP1999/004831 patent/WO2000004011A1/en not_active Ceased
- 1999-07-09 ES ES99934643T patent/ES2192853T3/es not_active Expired - Lifetime
- 1999-07-09 US US09/743,759 patent/US6528538B1/en not_active Expired - Fee Related
- 1999-07-09 CN CN99808783A patent/CN1309655A/zh active Pending
- 1999-07-09 DE DE69906303T patent/DE69906303T2/de not_active Expired - Fee Related
- 1999-07-09 HK HK02100966.8A patent/HK1039615A1/zh unknown
- 1999-07-09 CA CA002337481A patent/CA2337481A1/en not_active Abandoned
- 1999-07-09 PL PL99345397A patent/PL345397A1/xx unknown
- 1999-07-09 AU AU50347/99A patent/AU753287B2/en not_active Ceased
- 1999-07-09 BR BR9912138-7A patent/BR9912138A/pt not_active IP Right Cessation
-
2001
- 2001-01-16 NO NO20010266A patent/NO20010266L/no not_active Application Discontinuation
- 2001-02-15 ZA ZA200101303A patent/ZA200101303B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000004011A1 (en) | 2000-01-27 |
| KR20010070966A (ko) | 2001-07-28 |
| ZA200101303B (en) | 2002-05-15 |
| HUP0103411A2 (hu) | 2002-04-29 |
| EP1098893A1 (de) | 2001-05-16 |
| HK1039615A1 (zh) | 2002-05-03 |
| HUP0103411A3 (en) | 2002-08-28 |
| EP1098893B1 (de) | 2003-03-26 |
| NO20010266D0 (no) | 2001-01-16 |
| PT1098893E (pt) | 2003-08-29 |
| AU5034799A (en) | 2000-02-07 |
| CN1309655A (zh) | 2001-08-22 |
| ES2192853T3 (es) | 2003-10-16 |
| DE69906303D1 (de) | 2003-04-30 |
| SK482001A3 (en) | 2001-09-11 |
| DK1098893T3 (da) | 2003-07-07 |
| PL345397A1 (en) | 2001-12-17 |
| DE69906303T2 (de) | 2003-12-11 |
| BR9912138A (pt) | 2001-04-10 |
| US6528538B1 (en) | 2003-03-04 |
| ID27854A (id) | 2001-04-26 |
| AU753287B2 (en) | 2002-10-17 |
| JP2002520407A (ja) | 2002-07-09 |
| CA2337481A1 (en) | 2000-01-27 |
| FR2781222A1 (fr) | 2000-01-21 |
| NO20010266L (no) | 2001-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE235485T1 (de) | Cyclische verbindungen zur behandlung von dyslipidämien, atheriosklerose und diabetes, pharmazeutische zusammensetzungen und herstellungsverfahren | |
| ATE402180T1 (de) | Verbindungen zur behandlung von dyslipidemie | |
| ATE433447T1 (de) | Pyrimiidinverbindungen | |
| DE60214179D1 (de) | IMIDAZOi1,2-AöPYRIDIN-DERIVATE ZUR PROPHYLAXE UND BEHANDLUNG VON HERPES-INFEKTIONEN | |
| GB0305152D0 (en) | Organic compounds | |
| SE0104140D0 (sv) | Novel Compounds | |
| AP2003002915A0 (en) | HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis. | |
| MXPA03009840A (es) | Derivados de fenilurea sustituidos con carboxamida y metodo para la produccion de los mismos como farmacos. | |
| DE60211539D1 (de) | Imidazopyridinderivate zur verwendung bei der behandlung von herpes-vireninfektion | |
| EA200601555A1 (ru) | Замещенные индазол-о-глюкозиды | |
| EA200601554A1 (ru) | Замещенные индол-о-глюкозиды | |
| MXPA05012837A (es) | Inhibidores de caspasa y usos de los mismos. | |
| DE60326358D1 (de) | Fasern und fibride enthaltende artikel, fasern und fibride und herstellungsverfahren | |
| YU40002A (sh) | Antipikornavirusna jedinjenja i kompozicije, njihove farmaceutske upotrebe, i materijali za njihove sinteze | |
| ATE441632T1 (de) | Gesättigte und ungesättigte 3-pyridyl- benzocycloalkylmethyl-amine zur behandlung von schmerzen, depressionen und angstzuständen | |
| EA200800822A1 (ru) | Конъюгаты гидроксиалкилкрахмала и действующего вещества, полученные химическим лигированием через тиазолидин | |
| DE602004021363D1 (de) | Imidazotriazin verbindungen zur behandlung von krebserkrankungen | |
| SE0200844D0 (sv) | Chemical compounds | |
| ATE213233T1 (de) | Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit | |
| SE0303090D0 (sv) | Novel compounds | |
| HUP0302408A2 (hu) | Új aminotriazolon-vegyületek, eljárás ezek előállítására és ezeket tartalmazó gyógyászati készítmények | |
| ATE454383T1 (de) | Neue verbindungen, deren verwendung und herstellung | |
| DE602004023102D1 (de) | Verfahren zur herstellung kristalliner formen von orlistat | |
| CY1110156T1 (el) | Υποκατεστημενες ενωσεις 4,5,6,7-τετραϋδρο-βενζοθειαζολ-2-υλαμινης | |
| ATE417831T1 (de) | Ceramid ähnliche verbindungen, verfahren zu deren herstellung und deren verwendung als antitumormittel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1098893 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |